Zions Bancorporation’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$1.87M Buy
10,121
+1,594
+19% +$294K 0.12% 160
2024
Q3
$1.68M Buy
8,527
+1,275
+18% +$251K 0.12% 151
2024
Q2
$1.5M Sell
7,252
-234
-3% -$48.3K 0.12% 135
2024
Q1
$2.03M Buy
7,486
+303
+4% +$82.1K 0.15% 117
2023
Q4
$1.7M Buy
7,183
+456
+7% +$108K 0.12% 138
2023
Q3
$1.32M Buy
6,727
+1,473
+28% +$289K 0.12% 141
2023
Q2
$1.1M Buy
5,254
+294
+6% +$61.8K 0.09% 170
2023
Q1
$1M Buy
4,960
+574
+13% +$116K 0.09% 191
2022
Q4
$956K Buy
4,386
+1,847
+73% +$402K 0.08% 174
2022
Q3
$500K Buy
2,539
+2,536
+84,533% +$499K 0.05% 229
2022
Q2
$1K Sell
3
-3
-50% -$1K ﹤0.01% 1011
2022
Q1
$2K Sell
6
-88
-94% -$29.3K ﹤0.01% 1046
2021
Q4
$35K Buy
94
+4
+4% +$1.49K ﹤0.01% 514
2021
Q3
$37K Sell
90
-2,385
-96% -$981K ﹤0.01% 488
2021
Q2
$916K Buy
2,475
+295
+14% +$109K 0.09% 117
2021
Q1
$632K Sell
2,180
-14
-0.6% -$4.06K 0.07% 128
2020
Q4
$548K Buy
2,194
+67
+3% +$16.7K 0.07% 115
2020
Q3
$482K Sell
2,127
-87
-4% -$19.7K 0.07% 115
2020
Q2
$386K Buy
2,214
+189
+9% +$33K 0.06% 131
2020
Q1
$256K Buy
2,025
+177
+10% +$22.4K 0.04% 140
2019
Q4
$282K Sell
1,848
-469
-20% -$71.6K 0.04% 155
2019
Q3
$307K Sell
2,317
-104
-4% -$13.8K 0.04% 164
2019
Q2
$344K Buy
2,421
+124
+5% +$17.6K 0.05% 137
2019
Q1
$334K Buy
+2,297
New +$334K 0.05% 138
2018
Q2
Sell
-2,105
Closed -$225K 497
2018
Q1
$225K Buy
2,105
+160
+8% +$17.1K 0.05% 120
2017
Q4
$213K Sell
1,945
-20
-1% -$2.19K 0.04% 151
2017
Q3
$212K Buy
+1,965
New +$212K 0.03% 251
2016
Q3
Sell
-1
Closed 840
2016
Q2
$0 Buy
+1
New ﹤0.01% 839